drugset / Trial / NCT00371137

A Safety and Efficacy Study of Xyrem® in Subjects With Fibromyalgia

NCT00371137

Phase 3 Completed 548 enrolled Jazz Pharmaceuticals
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The objective of this trial is to evaluate the safety and efficacy of Xyrem® compared to placebo for the treatment of fibromyalgia in a randomized, double blind, placebo controlled, parallel group trial.

Timeline

Start
2006-08
Primary completion
2008-09
Completion
2008-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Sodium Oxybate Unknown 4.5 g
Subject Sodium Oxybate Unknown 6 g

Indications